Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis

Diagnostic Classifier for Cutaneous T-cell Lymphomas

NCT04491825 ·Status: UNKNOWN

Vaccine Therapy in Treating Patients With Lymphoplasmacytic Lymphoma

NCT01209871 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL

NCT03559413 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors

NCT00001301 ·Status: COMPLETED

Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma

NCT06588868 ·Status: RECRUITING

Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

NCT00720135 ·Status: COMPLETED ·Phase: PHASE1

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

NCT00398177 ·Status: RECRUITING

Ibrutinib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Older Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT01880567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Evaluate Rituximab in Obtaining PCR (Polymerase Chain Reaction) Negative Leukapheresis Product in Patients With Relapsed Follicular Lymphoma

NCT00856245 ·Status: COMPLETED ·Phase: PHASE2

Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma.

NCT00637117 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma

NCT01366157 ·Status: COMPLETED

Multiple Fields Radiotherapy Versus Intravenous Rituximab in the Treatment of Indolent Cutaneous Lymphomas B-cell With Multiple or Recurrent Lesions

NCT02867553 ·Status: UNKNOWN ·Phase: PHASE3

Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.

NCT05106192 ·Status: WITHDRAWN ·Phase: NA

Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

NCT01729104 ·Status: TERMINATED ·Phase: PHASE1

Prospective Study of Lymphoproliferative Diseases

NCT01704742 ·Status: WITHDRAWN

Long-term Use of Romidepsin in Patients With CTCL

NCT02296398 ·Status: COMPLETED

Treatment and Natural History Study of Lymphomatoid Granulomatosis

NCT00001379 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas

NCT02323659 ·Status: TERMINATED ·Phase: PHASE4

Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma

NCT02281279 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Ibrutinib After Intensive Induction in Treating Patients With Previously Untreated Mantle Cell Lymphoma

NCT02242097 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients

NCT01228461 ·Status: COMPLETED

Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas

NCT00001237 ·Status: COMPLETED ·Phase: PHASE2

An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

NCT06693973 ·Status: RECRUITING ·Phase: EARLY_PHASE1

A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting

NCT06794268 ·Status: RECRUITING

Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma

NCT00294632 ·Status: COMPLETED ·Phase: PHASE1/PHASE2